• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白90(Hsp90)抑制剂的研发与应用

Development and application of Hsp90 inhibitors.

作者信息

Solit David B, Chiosis Gabriela

机构信息

Department of Medicine and the Human Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, United States.

出版信息

Drug Discov Today. 2008 Jan;13(1-2):38-43. doi: 10.1016/j.drudis.2007.10.007. Epub 2007 Nov 26.

DOI:10.1016/j.drudis.2007.10.007
PMID:18190862
Abstract

Heat shock protein 90 has emerged as an important target in several diseases. The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections. It will also update the reader on the preclinical development and clinical translation of Hsp90 inhibitors.

摘要

热休克蛋白90已成为多种疾病的重要靶点。本综述将讨论我们对热休克蛋白90在调节和维持癌症及神经退行性疾病的转化表型中所起作用的理解,以及其在真菌和病毒感染中作用的最新研究结果。它还将向读者介绍热休克蛋白90抑制剂的临床前开发和临床转化情况。

相似文献

1
Development and application of Hsp90 inhibitors.热休克蛋白90(Hsp90)抑制剂的研发与应用
Drug Discov Today. 2008 Jan;13(1-2):38-43. doi: 10.1016/j.drudis.2007.10.007. Epub 2007 Nov 26.
2
Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.热休克蛋白90抑制剂:从格尔德霉素到当今药物的历程
Curr Opin Investig Drugs. 2006 Jun;7(6):534-41.
3
Hsp90: the vulnerable chaperone.热休克蛋白90:易损伴侣蛋白
Drug Discov Today. 2004 Oct 15;9(20):881-8. doi: 10.1016/S1359-6446(04)03245-3.
4
Heat shock protein 90: a unique chemotherapeutic target.热休克蛋白90:一个独特的化疗靶点。
Semin Oncol. 2006 Aug;33(4):457-65. doi: 10.1053/j.seminoncol.2006.04.001.
5
Purine-scaffold Hsp90 inhibitors.嘌呤骨架Hsp90抑制剂。
IDrugs. 2006 Nov;9(11):778-82.
6
Hsp90 as a therapeutic target in patients with oesophageal carcinoma.热休克蛋白 90 作为食管癌患者的治疗靶点。
Expert Opin Ther Targets. 2010 Mar;14(3):317-28. doi: 10.1517/14728221003621278.
7
HSP90 inhibitors: current development and potential in cancer therapy.热休克蛋白 90 抑制剂:在癌症治疗中的当前发展和潜力。
Recent Pat Anticancer Drug Discov. 2014 Jan;9(1):1-20.
8
Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.热休克蛋白90(Hsp90)作为胃肠道癌治疗的分子靶点。
Anticancer Res. 2009 Jun;29(6):2031-42.
9
Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress.靶向癌症伴侣蛋白HSP90:癌基因成瘾与肿瘤应激的联合治疗应用
Ann N Y Acad Sci. 2007 Oct;1113:202-16. doi: 10.1196/annals.1391.012. Epub 2007 May 18.
10
HSP90 inhibitors for cancer therapy and overcoming drug resistance.用于癌症治疗和克服耐药性的热休克蛋白90(HSP90)抑制剂
Adv Pharmacol. 2012;65:471-517. doi: 10.1016/B978-0-12-397927-8.00015-4.

引用本文的文献

1
Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Infection in BALB/c Mice: A Preclinical Study.腹腔注射17-DMAG作为BALB/c小鼠感染的有效治疗方法:一项临床前研究。
Pathogens. 2024 Jul 27;13(8):630. doi: 10.3390/pathogens13080630.
2
The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics.热休克蛋白与癌症发病机制之间的相互作用:一种癌症治疗的新策略。
Cancers (Basel). 2024 Feb 1;16(3):638. doi: 10.3390/cancers16030638.
3
Hsp90 β is critical for the infection of severe fever with thrombocytopenia syndrome virus.
Hsp90β 对于发热伴血小板减少综合征病毒的感染至关重要。
Virol Sin. 2024 Feb;39(1):113-122. doi: 10.1016/j.virs.2023.11.008. Epub 2023 Nov 24.
4
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells.加奈吉斯匹与甲氨蝶呤协同作用,抑制人肺癌A549细胞中的NF-κB/p65信号通路。
Pharmaceuticals (Basel). 2023 Feb 2;16(2):230. doi: 10.3390/ph16020230.
5
Anticancer Properties of Novel Bis-Triazoles.新型双三唑的抗癌特性
Curr Issues Mol Biol. 2022 Dec 29;45(1):175-196. doi: 10.3390/cimb45010014.
6
Alkaloid Derivative ()-3β-Ethylamino-Pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α.生物碱衍生物 ()-3β-乙基氨基孕甾-17(20)-烯通过靶向 HSP90α 抑制三阴性乳腺癌转移和血管生成。
Molecules. 2022 Oct 21;27(20):7132. doi: 10.3390/molecules27207132.
7
Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents.天然产物杂合子作为抗癌剂的最新进展。
Molecules. 2022 Oct 6;27(19):6632. doi: 10.3390/molecules27196632.
8
Novel Drugs with High Efficacy against Tumor Angiogenesis.新型高效抗肿瘤血管生成药物。
Int J Mol Sci. 2022 Jun 22;23(13):6934. doi: 10.3390/ijms23136934.
9
F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model.F 标记的二聚体-桑沙酰胺 A 环十肽:一种在裸鼠模型中区分胰腺癌与炎症的新型诊断探针。
J Cancer. 2022 Mar 21;13(6):1848-1858. doi: 10.7150/jca.69710. eCollection 2022.
10
Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells.HSP90抑制剂ganetespib与拉帕替尼的协同活性可逆转HER2阳性乳腺癌细胞对拉帕替尼的获得性耐药。
Front Pharmacol. 2021 Jul 5;12:651516. doi: 10.3389/fphar.2021.651516. eCollection 2021.